Detalhe da pesquisa
1.
All-cause mortality and disease progression in SARS-CoV-2-infected patients with or without antibiotic therapy: an analysis of the LEOSS cohort.
Infection
; 50(2): 423-436, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34625912
2.
Neurological symptoms and complications in predominantly hospitalized COVID-19 patients: Results of the European multinational Lean European Open Survey on SARS-Infected Patients (LEOSS).
Eur J Neurol
; 28(12): 3925-3937, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34411383
3.
Correction to: All-cause mortality and disease progression in SARS-CoV-2-infected patients with or without antibiotic therapy: an analysis of the LEOSS cohort.
Infection
; 50(2): 437-438, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34913136
4.
Hospitalized patients dying with SARS-CoV-2 infection-An analysis of patient characteristics and management in ICU and general ward of the LEOSS registry.
PLoS One
; 17(7): e0271822, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35905129
5.
Gastrointestinal bleeding and endoscopic findings in critically and non-critically ill patients with corona virus disease 2019 (COVID-19): Results from Lean European Open Survey on SARS-CoV-2 (LEOSS) and COKA registries.
United European Gastroenterol J
; 9(9): 1081-1090, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34655180
6.
Microsomal activation of dibenzo[def,mno]chrysene (anthanthrene), a hexacyclic aromatic hydrocarbon without a bay-region, to mutagenic metabolites.
Chem Res Toxicol
; 15(3): 332-42, 2002 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-11896680